anonymous
Guest
anonymous
Guest
FYI that your pay is about to change. JnJ Pharma/Biotech will be changing from a pay for performance system to a fixed system in 2017. There will be no bonus incentive compensation. Employees effected will be given raises to compensate ranging from zero increase on upward. All sales staffing are to be effected. This means the disparity of base pay among older, more tenured reps and the newer reps will be negated. This will likely cause many seasoned and high bonus reps to leave the organization. Ultimately this is a good faith move to the FDA ending decades of a lack of transparency. This is a similar program to what P&G and GSK enacted with much success. The move leaves many to wonder if a GSK and JnJ merger is not far off in the future.